Regulatory actions for Aug. 11, 2026Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Alebund, Aravax, Genesis Medtech, Innocare, Natera, Takeda, Transthera, Xellsmart, Zai Lab.